Navigation Links
Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting

ess than 0.5% of 774 patients with advanced colorectal cancer (mCRC) receiving ERBITUX. There was one case of ILD reported in 796 patients with head and neck cancer receiving ERBITUX in clinical studies.

In clinical studies of ERBITUX, dermatologic toxicities, including acneform rash, skin drying and fissuring, and inflammatory and infectious sequelae (eg, blepharitis, cheilitis, cellulitis, cyst) were reported. In 208 patients receiving ERBITUX + RT, acneform rash was reported in 87% (17% severe) as compared to 10% in 212 patients treated with radiation therapy alone (1% severe). In patients receiving ERBITUX alone, 76% (N=103) experienced acneform rash (1% severe). In patients with mCRC, acneform rash was reported in 89% (686/774) of all treated patients, and was severe in 11% (84/774). Subsequent to the development of severe dermatologic toxicities, complications including S. aureus sepsis and abscesses requiring incision and drainage were reported. Sun exposure may exacerbate these effects. A related nail disorder, occurring in 12% (0.4% Grade 3) of patients, was characterized as a paronychial inflammation.

The safety of ERBITUX in combination with radiation therapy and cisplatin has not been established. Death and serious cardiotoxicity were observed in a single-am trial with ERBITUX, delayed, accelerated (concomitant boost) fractionation radiation therapy, and cisplatin (100 mg/m2) conducted in patients with locally advanced squamous cell carcinoma of the head and neck. Two of 21 patients died, one as a result of pneumonia and one of an unknown cause. Four patients discontinued treatment due to adverse events. Two of these discontinuations were due to cardiac events (myocardial infarction in one patient and arrhythmia, diminished cardiac output, and hypotension in the other patient).

The incidence of hypomagnesemia (both overall and severe (NCI CTC Grades 3 & 4)) was increased in patients receiving ERBITUX alone or in combination with
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting
2. Genetic Analysis Systems Enter the Clinical Mainstream
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Extensive Clinical Data Erbitux Presented the ASCO Annual Meeting
(Date:5/5/2015)... 2015 The National Association of Specialty ... its 6 th Annual Most Influential in ... of Ear Professionals International Corporation (dba EPIC Hearing ... the nation, EPIC Hearing Service Plans cover millions ... organizations, employers, health plans, unions and through partnerships ...
(Date:5/5/2015)...  Stryker Orthopaedics announced today its return to THE ...  Since becoming the "Official Joint Replacement Products of ... ago, the company has made 14 stops along the ... activation the Stryker Mobility Zone – a destination designed ... health. Proving to be a successful program, Stryker has ...
(Date:5/5/2015)... 2015  Vaccinogen, Inc. (OTC.QB: VGEN), a cancer immunotherapy ... has unanimously elected Co-founder, President, Chief Executive Officer and ... role of Chairman of the Board. Mr. Tussing replaces ... from the Board and his role as Chairman and ... pursue his candidacy for the President of ...
Breaking Medicine Technology:EPIC Hearing Healthcare CEO Brad Volkmer Awarded 6th Annual Most Influential In Specialty Health 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 3Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 2Vaccinogen Names Co-Founder and CEO Andrew L. Tussing as Chairman of the Board 3
... Accuray Incorporated, a global leader in the field of ... to address the unique technical, business and operational needs ... a means for sites to receive upgrades and technology ... program, named Diamond Plus, continues to push the innovative ...
... Oct. 29 Echo Therapeutics, Inc. (OTC Bulletin Board: ... Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous ... transdermal drug delivery, today announced that Patrick T. Mooney, ... Echo Therapeutics will present at the LifeTech Capital 1st ...
Cached Medicine Technology:Accuray Announces Expanded Service Program 2Accuray Announces Expanded Service Program 3Accuray Announces Expanded Service Program 4Echo Therapeutics to Present at the LifeTech Capital 1st Annual Miami Medical Investors Conference 2
(Date:5/5/2015)... Burnie, MD (PRWEB) May 05, 2015 ... in an upcoming episode of Innovations with Ed Begley ... and show times TBA. , This segment will focus ... home testing. Viewers will learn about their AccuSom® home ... sleep test that provides continuous patient support and next-day ...
(Date:5/5/2015)... 2015 After record-breaking sales of ... Walgreens introduces the Cookies & Cream flavor at stores ... Nutrition has continually raised the bar for nutritional snacks. ... with an unprecedented nutritional profile, backed by international patents ... Nutrition will launch additional new products and expand retail ...
(Date:5/5/2015)... After conducting a nationwide executive search ... Smith, West Holt Medical Services in Atkinson, ... A skilled healthcare executive with more than 10 years ... on June 1st. , “Brad brings a proven track ... understanding and success in building strong relationships with physicians,” ...
(Date:5/5/2015)... Louis, MO (PRWEB) May 05, 2015 The ... 12, 2015 from 5:00 to 8:00 pm at the Rochester ... 50 hospitals, clinics and groups with career opportunities will be ... Attendees will enjoy free hors d’oeuvres and raffle prize drawings. ... says, “Rochester is an ideal location to hold a ...
(Date:5/5/2015)... Cincinnati, OH (PRWEB) May 05, 2015 ... healthcare ministry serving Ohio and Kentucky – has devoted ... Be Well videos to childhood obesity issues. Experts say ... In a concise video on Mercy Health’s YouTube channel, ... ,     Why is childhood obesity worse now ...
Breaking Medicine News(10 mins):Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:West Holt Medical Services Hires New Chief Executive Officer 2Health News:West Holt Medical Services Hires New Chief Executive Officer 3Health News:PracticeMatch to Host Physician Career Fair at the Rochester Marriott on May 12, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Rochester Marriott on May 12, 2015 3Health News:Videos provide helpful information about childhood obesity 2
... on the target areas, where ADHD drugs act, researchers ... (PFC) region of the brain //rather than on accumbens ... University of Wisconsin-Madison found how the drug Ritalin used ... (ADHD), works in the brain. ,But ...
... with prostate cancer are more influenced by anecdote, misconception ... on clinical trial evidences. ,Research showed ... anecdotal experiences of others with prostate cancer to their ... entirely different from them are the reasons for waving ...
... Rheumatoid arthritis are also prone to have sexual problems. The ... against rheumatism congress. ,Rheumatoid arthritis occurs in elderly ... and inflammation of the joints. It is a chronic disease ... ,According to the study it was found that ...
... that was begun some six years ago has finally begun ... by mobile doctors //thereby getting the care they need without ... of a 33-foot-vehicle that would travel to schools in Garland, ... This has helped teens to get the care they need ...
... properly funding the cholesterol lowering drugs to the new Zealanders. ... which they point out the shortsighted approach of the agency ... and Dr Harvey White said that the agency did not ... years. ,Statins are drugs which help in the ...
... P. Viswanatham Government Medical College Hospital not in the list ... // ,There is an increased bitterness among the ... ministry of health of not including K. A. P. Viswanatham ... with the ,All India Institute of Medical Sciences (AIIMS), New ...
Cached Medicine News:Health News:Effect of ADHD Drugs on the Brain - Study Finds 2Health News:Effect of ADHD Drugs on the Brain - Study Finds 3Health News:Misconception on Treatment Options among Prostate Cancer Patients 2Health News:Increased Demand For Up-gradation Local Hospital In Tiruchy 2
Inorganic phosphorus reagent is used for the quantitative determination of inorganic phosphorus in human serum....
Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum....
For the kinetic quantitative determination of g-Glutamyl Transferase in serum for manual and/or automated procedures....
g-GT Liquid Reagent (Kinetic Method). Wavelength: 405 nm. Linear range: 0-200 U/mL. Prepare Working Reagent in the ratio of 5 parts R1 to 1 part of R2, (i.e., 50 mL R1 and 10 mL R2)....
Medicine Products: